Increased Intraocular Pressure. Ocular Hypertension
Conditions
Interventions
Intervention 1: Intervention Group:The Magnesium Sulfate was Solved in 100cc Normal Saline and Infused within 20 Minutes in the Treatment Group. Intervention 2: Control group:100 cc Normal Saline was
Treatment - Drugs
Placebo
Intervention Group:The Magnesium Sulfate was Solved in 100cc Normal Saline and Infused within 20 Minutes in the Treatment Group
Control group:100 cc Normal Saline was Infused to Patients in the Control Group Before the Operation
Sponsors
Vice Chancellor for Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Adult patients, ASA I and II, weighting between 50 to 80 kg, Patients who had been Scheduled for Laparoscopic Cholecystectomy. Exclusion criteria: Arrhythmia in ECG, Cardiac Disease, Musculoskeletal Diseases like Myasthenia Grove,Renal Failure, Acute or Chronic Eye Disease, History of Using any Drugs that Affects Intraocular Pressure.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of Magnesium Sulfate on the Intraocular Pressure. Timepoint: During Larangoscopy and Intubation. Method of measurement: Tonopen. | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of Magnesium Sulfate on the Intraocular Pressure. Timepoint: During CO2 Insufflation. Method of measurement: Tonopen. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdolsamad Saleh
Shiraz University of Medical Sciences
Outcome results
None listed